Notre Dame-Eli Lilly & Co. Faculty Fellowship Program in Drug Discovery
The Notre Dame-Eli Lilly & Co. Faculty Fellowship Program in Drug Discovery provides a stipend for a Notre Dame faculty member to be a visiting scholar and experience, firsthand, the drug discovery and development process at Eli Lilly & Co. The fellow will shadow a team of Lilly scientists and project managers within the chemistry program in Indianapolis, Indiana for a period of at least two to three months. ND-Lilly Fellows will have the opportunity to consult on project-related issues, collaborate with Lilly scientists on research questions, present seminars on topics of mutual interest, and stimulate new connections between Lilly and Notre Dame researchers.
Projects will align within areas of Lilly’s current drug discovery interests, including oncology, diabetes, neurodegeneration, autoimmune disorders, and pain.
Individual project assignments will be determined by mutual agreement of the faculty researcher and the host scientist at Lilly.
The following categories are eligible to apply for this program:
- All tenured, tenure-track, and research University of Notre Dame faculty with an interest in the drug discovery process are invited participate in this opportunity.
A stipend will be provided to help offset the costs of local housing.
The grant application deadline is January 27, 2017 at 5:00 p.m. EST.
Proposal Format and Submission
Interested applicants should submit a letter of interest via email, including a proposed start and end date, and a NIH-style biosketch addressed to Richard Taylor, Professor of Chemistry and Biochemistry and Interim Director of the Warren Family Research Center for Drug Discovery and Development
Note: All fellowship requests from tenured or tenure-track faculty during the academic year must be approved through the normal departmental sabbatical leave policy.
A number of University of Notre Dame administrative units, including Notre Dame Research, the Dean’s Offices in the Colleges of Engineering and Science, the Harper Cancer Research Institute, the Boler-Parseghian Center for Rare and Neglected Diseases, and the Warren Family Research Center for Drug Discovery and Development, have come together to create this new fellowship program. Its goal is to further develop Notre Dame’s research relationship with Eli Lilly, a world leader in the development of new medicines and new models for scientific innovation, and to support faculty who wish to gain knowledge and practical experience in the pharmaceutical industry.
Need more information?
For information on the Eli Lilly program, please contact Richard Taylor, Professor of Chemistry and Biochemistry and Acting Director of the Warren Family Research Center for Drug Discovery and Development.